Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP386134.RAvVmzDNk4xxFzT0EOadjLrHvADILWIxB2OYcNHXIJ7ak130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386134.RAvVmzDNk4xxFzT0EOadjLrHvADILWIxB2OYcNHXIJ7ak130_provenance.
• NP386135.RAmYkUCPRAW4fWNtYPuibtUvDCtOS01J72BmHFKt1TxEY130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386135.RAmYkUCPRAW4fWNtYPuibtUvDCtOS01J72BmHFKt1TxEY130_provenance.
• NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913972.RAN-4mFbq7TeV_KFk8eTo8eGineEmCUlwDsFS2nyjRc1I130_provenance.
• NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_provenance.
• NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_provenance.
• NP386137.RAGZE2l2gcQgNdDXehjgynGA1QRyCaCJHzuTP-d-DpyDM130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386137.RAGZE2l2gcQgNdDXehjgynGA1QRyCaCJHzuTP-d-DpyDM130_provenance.
• NP386138.RAGkN36vP2z57wzfIM5XeP63mUvGXOEWfTT5dNewKUyPU130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386138.RAGkN36vP2z57wzfIM5XeP63mUvGXOEWfTT5dNewKUyPU130_provenance.
• NP873147.RAJoiLlxbjJgarYKkY9uY9T4LLz2Uac0Iohdly-FxdxJ4130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873147.RAJoiLlxbjJgarYKkY9uY9T4LLz2Uac0Iohdly-FxdxJ4130_provenance.
• NP978481.RAE1PSz9UKlbu48CSA5EFewR1hKQPSqZ43pyjUj1GWdhI130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978481.RAE1PSz9UKlbu48CSA5EFewR1hKQPSqZ43pyjUj1GWdhI130_provenance.
• NP386136.RA4H6eWGC5kbF4Sa-nkuUL6lc7duPl0lhUrr_hoj4lco8130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386136.RA4H6eWGC5kbF4Sa-nkuUL6lc7duPl0lhUrr_hoj4lco8130_provenance.